📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Ra Pharma

1.1 - Company Overview

Ra Pharma Logo

Ra Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of Cyclomimetics, a new drug class combining the diversity and specificity of antibodies with the benefits of small molecules; leveraging rapid generation of drug candidates to build a portfolio and partnerships focused on intracellular protein-protein interactions.

Products and services

  • Cyclomimetics: Ra Pharma engineers a new-class drug family combining antibody-like diversity and specificity with small-molecule benefits, enabling therapeutic applications that address intracellular protein-protein interactions
  • Drug Candidate Generation: Ra Pharma architects rapid-generation candidates, leveraging antibody specificity and small-molecule advantages to build its own portfolio of products aimed at intracellular protein-protein interaction targets
  • Partnerships: Ra Pharma delivers intracellular-focused collaborations, developing products and alliances around protein-protein interactions while capitalizing on Cyclomimetics’ antibody diversity and specificity and the many benefits of small molecules

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Ra Pharma

ChemConnection Logo

ChemConnection

HQ: The Netherlands Website
  • Description: Provider of pharmaceutical ingredients and nanomedicines development.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ChemConnection company profile →
EnginZyme Logo

EnginZyme

HQ: Sweden Website
  • Description: Provider of a patented cell-free biomanufacturing platform and services for the sustainable production of common goods. Offers EziG immobilized enzyme cascades enabling continuous, organism-free operation; automated biocatalyst design; integrated bioprocess engineering and scale-up from catalyst design to commercialization; and a patented enzymatic pseudouridine synthesis for mRNA vaccines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EnginZyme company profile →
Repligen Logo

Repligen

HQ: United States Website
  • Description: Provider of consumable bioprocessing products and systems for manufacturing biological drugs, including KrosFlo TFF systems for ultrafiltration, diafiltration and microfiltration; XCell ATF cell-retention systems, available in single-use or stainless steel formats; NGL COVID-19 spike protein affinity resin; CTech FlowVPX in-line spectrophotometry for GMP testing; ProConnex single-use flow paths; and fluid storage and transfer solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Repligen company profile →
Microbia Logo

Microbia

HQ: United States Website
  • Description: Provider of industrial biotechnology, developing, producing, and commercializing fermentation-based specialty ingredients and biomaterials, including carotenoids, biopolymers, and other biomaterials; maintains a strategic alliance with Tate & Lyle Investments.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Microbia company profile →
Axion Biosystems Logo

Axion Biosystems

HQ: United States Website
  • Description: Provider of multi-electrode array and impedance-based platforms for real-time, continuous, label-free cellular analysis, including monitoring of proliferation, viability, morphology, attachment, signaling, and immune cell-mediated killing. Offers single- and multi-well systems, high-throughput formats, automation modules, and integrated circuits to eliminate stimulation artifacts for research, clinical, and drug discovery markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Axion Biosystems company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Ra Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Ra Pharma

2.2 - Growth funds investing in similar companies to Ra Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Ra Pharma

4.2 - Public trading comparable groups for Ra Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Ra Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Ra Pharma

What does Ra Pharma do?

Ra Pharma is a provider of Cyclomimetics, a new drug class combining the diversity and specificity of antibodies with the benefits of small molecules; leveraging rapid generation of drug candidates to build a portfolio and partnerships focused on intracellular protein-protein interactions.

Who are Ra Pharma's competitors?

Ra Pharma's competitors and similar companies include ChemConnection, EnginZyme, Repligen, Microbia, and Axion Biosystems.

Where is Ra Pharma headquartered?

Ra Pharma is headquartered in United States.

How many employees does Ra Pharma have?

Ra Pharma has 1,000 employees 🔒.

When was Ra Pharma founded?

Ra Pharma was founded in 2010 🔒.

What sector and industry vertical is Ra Pharma in?

Ra Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Ra Pharma

Who are the top strategic acquirers in Ra Pharma's sector and industry

Top strategic M&A buyers and acquirers in Ra Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Ra Pharma?

Top strategic M&A buyers groups and sectors for Ra Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Ra Pharma's sector and industry vertical

Which are the top PE firms investing in Ra Pharma's sector and industry vertical?

Top PE firms investing in Ra Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Ra Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Ra Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Ra Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Ra Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Ra Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Ra Pharma?

The key public trading comparables and valuation benchmarks for Ra Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Ra Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Ra Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Ra Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Ra Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Ra Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Ra Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Ra Pharma